Clinical Trial: Clinical Trials of IBI3040 in Healthy Participants and Overweight or Obese Participants

U.S., Aug. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07765160) titled 'Clinical Trials of IBI3040 in Healthy Participants and Overweight or Obese Participants' on Aug. 11.

Brief Summary: Clinical trials of IBI3040 with single-dose administration in healthy participants and multiple-dose administration in overweight or obese participants.

Study Start Date: Aug. 30

Study Type: INTERVENTIONAL

Condition: Healthy Participants Overweight or Obese Participants

Intervention: DRUG: SAD: subcutaneous injection in the abdomen

SAD: Single subcutaneous administration, with a safe follow-up period of 60 days

DRUG: MAD: subcutaneous injection in the abdomen

MAD: Multiple administration, subcutaneous injectio...